QHR Technologies Inc. Market Share Analysis
GlobalData’s new report, “QHR Technologies Inc. Market Share Analysis” provides in-depth information on QHR Technologies Inc..’s market position in the clinical IT systems market. The report also provides data and information on the overall competitive landscape within the clinical IT systems market. The report is supplemented with global corporate-level profile with information on the company’s business segments, major products and services, competitors, locations and subsidiaries, financial deals and other key developments.
This report is built using data and information sourced from proprietary databases, primary and secondary research and in-house analysis by GlobalData’s team of industry experts.
- Global company shares (in Revenues) information for the clinical IT systems market.
- QHR Technologies Inc..’s company shares (in Revenues) information for all the key countries the company has presence in -Canada.
- QHR Technologies Inc..’s company shares (in Revenues) information for the clinical IT systems market.
- All the key data-points are for 2011 and cover all the key region – North America.
- Global corporate-level profile with information on the company’s business segments, major products and services, competitors, and locations and subsidiaries.
- The company profile is also supplemented with a SWOT Analysis with in-depth information and analysis of the company’s value proposition and the business climate it operates in.
- Comprehensive coverage of the latest financial deals involving the company and its subsidiaries.
Reasons to buy
- Develop sales and marketing strategies by identifying who-stands-where in the markets, QHR Technologies Inc..’s operates in.
- Plan your competition strategies by identifying the company’s shares in the markets and geographic regions it operates in.
- Design your own inorganic growth and business-collaboration strategies by understanding the financial deals your competitors are involved in.
- Advance your understanding of the competitive landscape and the competitors by leveraging on the data and information provided in the report.
- Support your overall business strategies by leveraging on the key data and information provided in the report, which includes but not limited to QHR Technologies Inc..’s market positions.
QHR Technologies Inc. Market Share Analysis
1 Table of Contents
1 Table of Contents 2
1.1 List of Tables 6
1.2 List of Figures 6
2 Introduction 7
2.1 What Is This Report About? 7
3 Definitions of Markets/Categories Covered 8
3.1 Healthcare IT 8
3.1.1 Clinical IT Systems 8
4 Company Snapshot 9
4.1 Key Facts 9
4.2 Company Overview 9
4.3 Financial Performance 9
4.4 SWOT Snapshot 9
4.5 Business Overview 10
4.6 Major Products and Services 10
4.6.1 Overview 10
5 History 11
6 SWOT Analysis 14
6.1 Overview 14
6.2 QHR Technologies Inc. Strengths 14
6.2.1 Niche Market Offerings 14
6.2.2 Management Team 14
6.2.3 Expanding Operating Margin 15
6.3 QHR Technologies Inc. Weaknesses 15
6.3.1 Limited Liquidity Position 15
6.3.2 Geographical Concentration 15
6.4 QHR Technologies Inc. Opportunities 15
6.4.1 Strategic Acquisitions 15
6.4.2 Growing Cloud Computing Markets 15
6.4.3 Growing Global Healthcare-IT Market 16
6.5 QHR Technologies Inc. Threats 16
6.5.1 Global Economic Scenario 16
6.5.2 Rapid Technological Change 16
6.5.3 Government Laws and Regulations 16
7 Competitors 17
8 Competitive Landscape 19
8.1 Healthcare IT (Clinical IT Systems), Global, Market Share (%), 2011 19
8.2 QHR Technologies Inc., Healthcare IT(Clinical IT Systems), by Region, Market Share (2011) 21
8.3 QHR Technologies Inc., Healthcare IT(Clinical IT Systems), by Country, Market Share (2011) 21
9 Key Employees 22
10 Key Employee Biographies 23
11 Company Statement 24
12 Locations And Subsidiaries 26
12.1 Head Office 26
12.2 Other Locations & Subsidiaries 26
13 Financial Deals Landscape 27
13.1 QHR Technologies Inc., Deals Volume Summary, 2006 to YTD 2012 27
14 QHR Technologies Inc. Detailed Deal Summary 29
14.1 Asset Purchase 29
14.1.1 Optimed Software Corporation Of QHR Technologies Acquires MediCentre Assets From iQmedX Software 29
14.2 Equity Offering 30
14.2.1 QHR Technologies Completes Private Placement Of Units For $1 Million 30
14.2.2 QHR Technologies Completes Private Placement Of $1.06 Million 32
14.2.3 CLINICARE Completes Private Placement Of $3 Million 33
14.3 Acquisition 34
14.3.1 QHR Technologies Completes Acquisition Of Open EC Technologies 34
14.3.2 QHR Technologies Completes Acquisition Of EMIS 36
14.3.3 QHR Technologies Completes Acquisition Of CLINICARE 37
14.3.4 QHR Technologies Acquires National Medical Solutions 38
15 Recent Developments 39
15.1 Financial Announcements 39
15.1.1 Nov 09, 2012: QHR Reports Revenue Of CAD7m In Q3 2012 39
15.1.2 Aug 23, 2012: QHR Reports Revenue Of CAD6.9m In Q2 2012 39
15.1.3 May 10, 2012: QHR Reports Revenue Of CAD7.4m In Q1 2012 40
15.1.4 Apr 17, 2012: QHR Reports Revenue Of CAD23.9m In 2011 40
15.1.5 Nov 17, 2011: QHR Reports Revenue Of CAD5.5m In Q3 2011 41
15.1.6 Aug 22, 2011: QHR Reports Revenue Of CAD5.2m In Q2 2011 41
15.1.7 Jun 20, 2011: QHR Reports Total Revenue Of $6.5m In Q1 2011 42
15.1.8 Apr 29, 2011: QHR Reports Revenue Of $19.1m In 2010 43
15.1.9 Nov 25, 2010: QHR Reports Revenue Of $4.6m In Q3 2010 44
15.1.10 Aug 16, 2010: QHR Reports Revenue Of $5.1m In Q2 2010 45
15.1.11 May 27, 2010: QHR Reports Revenue Of $4.7m In Q1 2010 46
15.1.12 May 13, 2009: QHR Posts Total Revenues Of $3.4 million In Q1 2009 46
15.1.13 Apr 20, 2009: QHR Posts Total Revenues Of CAD6.52 Million For 2008 47
15.1.14 Nov 28, 2008: QHR Reports Q3 2008 Results 48
15.1.15 Aug 06, 2008: QHR Reports 2Q 2008 Results 49
15.1.16 Apr 21, 2008: QHR Declares Q1 2008 Results 50
15.1.17 Mar 25, 2008: QHR Declares 2007 Results 50
15.1.18 Nov 27, 2007: QHR Declares Nine Months Ended 2007 Results 52
15.1.19 Aug 17, 2007: QHR Declares First Six Months Ended 2007 Results 52
15.1.20 May 28, 2007: QHR Declares Q1 2007 Results 54
15.2 Corporate Communications 55
15.2.1 Sep 24, 2012: QHR Appoints Gordon Glenn As Chairman 55
15.2.2 Jun 05, 2012: QHR Appoints Jerry Diener As CFO 56
15.2.3 May 19, 2011: QHR Names John Gillberry As Executive Vice President, CFO 56
15.2.4 Oct 15, 2009: QHR Appoints Victoria Withers To Board 57
15.2.5 Sep 30, 2008: QHR Appoints New Board Member 57
15.2.6 Jul 16, 2007: QHR Appoints Board Member 58
15.2.7 Jun 11, 2007: QHR Appoints CFO 58
15.3 Legal and Regulatory 59
15.3.1 Aug 24, 2011: QHR's EMR Division Achieves ISO 13485:2003 Certification 59
15.4 Other Significant Developments 59
15.4.1 Nov 07, 2007: QHR Subsidiary Wins New Contract 59
16 Appendix 60
16.1 Research Methodology 61
16.2 Secondary Research 61
16.3 Primary Research 62
16.4 Models 62
16.5 Forecasts 62
16.6 Expert Panels 63
16.7 GlobalData Consulting 63
16.8 Currency Conversion 64
16.9 Contact Us 65
16.10 Disclaimer 65
1.1 List of Tables
Table 1: QHR Technologies Inc., Key Facts, 2011 9
Table 2: QHR Technologies Inc., SWOT Analysis, 2011 14
Table 3: Healthcare IT (Clinical IT Systems), Global, Company Share by Revenue ($m), 2011 20
Table 4: QHR Technologies Inc., Healthcare IT (Clinical IT Systems), by Region, Revenue ($m) and Market Share (%), 2011 21
Table 5: QHR Technologies Inc., Healthcare IT (Clinical IT Systems), by Country, Revenue ($m) and Market Share (%), 2011 21
Table 6: QHR Technologies Inc., Key Employees 22
Table 7: QHR Technologies Inc., Subsidiaries 26
Table 8: QHR Technologies Inc., Deals Volume Summary, 2006 to YTD 2012 27
Table 9: QHR Technologies Inc., Deals Summary, 2006 to YTD 2012 28
Table 10: Optimed Software Corporation Of QHR Technologies Acquires MediCentre Assets From iQmedX Software 29
Table 11: QHR Technologies Completes Private Placement Of Units For $1 Million 30
Table 12: QHR Technologies Completes Private Placement Of $1.06 Million 32
Table 13: CLINICARE Completes Private Placement Of $3 Million 33
Table 14: QHR Technologies Completes Acquisition Of Open EC Technologies 34
Table 15: QHR Technologies Completes Acquisition Of EMIS 36
Table 16: QHR Technologies Completes Acquisition Of CLINICARE 37
Table 17: QHR Technologies Acquires National Medical Solutions 38
Table 18: USD to Local Currency, Average Exchange Rate, 2011 64
1.2 List of Figures
Figure 1: Healthcare IT (Clinical IT Systems), Global, Market Share (%), 2011 19
Figure 2: QHR Technologies Inc., Deals Volume Summary, 2006 to YTD 2012 27
- Challenges in the Tourism Industry in Thailand
Thailand has always been a popular tourist destination and tourism provides a major boost to the country’s economy. Bangkok, Hua Hin, Krabi, Samui, Phuket and Cha Am are some of the most attractive tourist destinations in the country. In 2012, Thailand had a very high number of arrivals. Even the number of Thai citizens who [...]
- Future of the US Consumer Electronics Market
The market for consumer electronics has been growing steadily. Some of the factors that are contributing to the growth in the market are technological advancement, rise in disposable income and increasing demand for new products. During 2012, consumer electronics market in the US demonstrated positive expansion, although the growth rate slowed down considerably following the [...]
- Overview of the Global Retail Market
The global retail industry continued to grow despite the difficult economic conditions in the world. In the fiscal year of 2011, sales-weighted, currency-adjusted revenue rose by 5.1% to $4.271 trillion for the world’s top 250 retailers. According to GRDI (Global Retail Development Index), in 2013 Brazil occupied the top spot in retail development. Chile and [...]
- Bright Future Predicted for the Tourism Industry in Singapore
Travel and tourism industry in Singapore has been growing at a steady rate and is considered to be a major contributor to the economic growth of the country. In 2012, Singapore’s IVA (International Visitors Arrivals) reached a record high of 14.5 million, with a growth rate of 10.1% year-on-year. In recent years, inbound travel to [...]
- Potential of Staffing Market in United States
The staffing industry places individuals into contract, temporary and permanent positions in firms around the world. Major staffing markets include France, Spain, Italy and Japan as well as many emerging markets. Temporary staffing around the world has been growing, but in US temporary market has been flat since 2006. The majority of staffing revenue majorly [...]
- Graft-Versus-Host Disease (GVHD) Treatment Market worth $407 million by 2018
The graft-versus-host disease (GVHD) treatment market value will increase from $297 million in 2013 to $407 million by 2018, at a Compound Annual Growth Rate (CAGR) of 6.59%, according to research and consulting firm GlobalData. The company’s latest report* states …
- Poland Pharmaceutical Industry Growing at 8.3% CAGR to 2020
Factors such as the growing elderly population, increasing availability of affordable medicines, and transparent regulatory guidelines will provide the necessary impetus for the growth of the Polish pharmaceutical market, but a decrease in mark-up prices and the country’s stringent drug …
- Asia-Pacific, Led by China, Drive the Global Methanol Industry
China is driving the global methanol industry, with tremendous demand from both its energy and petrochemicals sectors. It accounts for 87.9% of Asia-Pacific’s (APAC) methanol capacity, and 51.9% of the global methanol capacity. Despite a large planned capacity increase in …
- Diagnostic X-ray Imaging Market worth $4.0 billion by 2020
GlobalData estimates that the global diagnostic X-ray imaging market, worth $2.4 billion in 2012, will reach almost $4.0 billion by 2020, increasing at a Compound Annual Growth Rate (CAGR) of 6.7% during the forecast period. Many players are active in …
- Graft-Versus-Host Disease Market Forecast to 2023
Graft-versus-host disease (GVHD) is a common complication of allogeneic hematopoietic stem cell transplantation (HSCT) that occurs when the donated (graft) cells are rejected and attack the host’s cells as foreign. GVHD can progress from mild to severe forms as either …
Global Hyaluronic Acid (HA) Market 2014-2018
Published: 22-Oct-2014 Price: US $2500 Onwards Pages: 80
Hyaluronic acid (HA) or glass acid is a naturally occurring non-sulfated glycosaminoglycan. It is present in the human body in the joints, eye cavity, and internal defense systems. It functions as a nutrient carrier, along with helping the tissues in retaining water. It is an integral part of the extracellular matrix and is found in the coverings around chondrocytes. HA is produced commercially by various processes, including extraction from animal tissues, bacterial production, and in-vitro pro......
Switzerland Pharmaceuticals and Healthcare Report Q4 2014
Published: 22-Oct-2014 Price: US $1295 Onwards Pages: 102
BMI View: Most of Switzerland's demographic and economic indicators are favourable towards increased
pharmaceutical and healthcare spending. The proportion of the pensionable population is high and
growing, and this will translate into greater demand for drugs. Furthermore, the country's highly developed
infrastructure means that access to healthcare is easy, further supporting the consumption of medicines.
Headline Expenditure Projections
? Pharmaceuticals: CHF7.06bn (USD7.68bn) in 2013 to CHF7......
United Kingdom Pharmaceuticals and Healthcare Report Q4 2014
Published: 22-Oct-2014 Price: US $1295 Onwards Pages: 119
BMI View: The decline in NHS pharmaceutical expenditure in 2013, despite an increase in prescription
numbers, does not come as a surprise and is expected to continue beyond 2014. This drop in spending
reflects the UK government's focus on containing costs within the healthcare sector, and in particular
Headline Expenditure Projections
Pharmaceuticals: GBP23.32bn (USD36.15bn) in 2013 to GBP22.90bn (USD37.33bn) in 2014;
-1.8% in local currency terms and +3.3% in US doll......
Global Peptide Therapeutics Market 2014-2018
Published: 22-Oct-2014 Price: US $2500 Onwards Pages: 83
Peptides are amino acids sequences and among the most potent biologically active substances found in nature. Peptides are used to control, trigger, and maintain physiological processes in living beings. However, the use of peptides as therapeutic agents has always been difficult because of their inherent instability and incapability to cross cellular membranes. Peptides also entail the requirement of specific technology to tackle the extensive and challenging steps in their synthesis. Currently,......
Venezuela Pharmaceuticals and Healthcare Report Q4 2014
Published: 22-Oct-2014 Price: US $1295 Onwards Pages: 132
BMI View: Venezuela's improving foreign currency supply, increasing pharmaceutical imports from
political allies and the potential expansion of free medicine coverage in the public sector will ease the
shortage of local medicines in the near term. However, fundamental issues - such as price controls, high
inflation, currency devaluation, import and foreign currency controls and the government's attitude towards
normal business practices - have not changed. We therefore maintain the bearish view ......
Global Continuous Glucose Monitoring Market 2014-2018
Published: 22-Oct-2014 Price: US $2500 Onwards Pages: 60
Continuous glucose monitoring is the measurement of glucose levels at regular intervals from a diabetic patient. Continuous glucose monitoring systems allow to gain insight into the trends of glucose levels between fingersticks, resulting in improved glucose control. Continuous glucose monitoring system comprises of a glucose sensor that is placed subcutaneously to provide the reading of glucose levels in tissue fluid. A transmitter sends information about the glucose levels using radio waves fr......
Global Renal Dialysis Market 2014-2018
Published: 22-Oct-2014 Price: US $2500 Onwards Pages: 88
The kidney is an important organ, which helps in maintaining the internal equilibrium of water and minerals. Renal dialysis is the process of the removing toxin substances such as creatinine and urea and excess amount of free water from the blood. Dialysis is a treatment used when in acute and chronic disturbance in the functioning of the kidney. Renal dialysis plays a major role in improving patients' quality of life.
TechNavio's analysts forecast the Global Renal Dialysis market to grow at ......
Iraq Pharmaceuticals and Healthcare Report Q4 2014
Published: 22-Oct-2014 Price: US $1295 Onwards Pages: 79
The long-term prospects for the Iraqi pharmaceutical and healthcare markets remain promising given rising
healthcare expenditure as well as further population growth. The Iraqi government has reportedly pledged to
invest USD12bn into healthcare expansions in 2014, and the Ministry of Health recently awarded 18 health
project contracts worth USD276mn. However, the projected growth of Iraq's pharmaceutical market in 2014
and 2015 is linked to an oil-driven economic expansion, which is dependent on......
Kuwait Pharmaceuticals and Healthcare Report Q4 2014
Published: 22-Oct-2014 Price: US $1295 Onwards Pages: 122
BMI View: Notwithstanding a recent escalation in political uncertainty, Kuwait's healthcare sector is
forecast to preserve its trajectory of modest growth throughout the remainder of 2014. Rising sales are
underpinned by an expanding population, whose levels of chronic conditions increasingly call for the
supply of long-term treatments and cutting-edge medical equipment. In addition, apprehension towards fake
generics and an accompanying government crackdown have further solidified popular deman......
Value for Money
We believe in "optimum utilization of available budget and resources". While servicing our clients' (your) market research requirements, we keep the same approach in focus to help you get the best value for your $$s.
Ever Growing Inventory
Ranging from the smallest feasible / required data (datasheets, data facts, SWOT analysis, company profiles, etc) to full research reports that help you make decisions, our inventory is updated almost on a daily basis with the latest industry reports from domain experts that track more than 5000 niche sectors.
One Stop Solution
Need a custom research report on medical devices market? Require all available business intelligence on 3D printing industry? Exploring F&B sector of a particular country/region? RnRMarketResearch.com is your one-stop-solution to all market intelligence needs. We not only offer custom research and consulting services, we also "bundle" reports to meet your needs and help you fetch the data analysis you require for your business.
Dedicated Client Engagement
Not limited to only "finding" relevant reports for you, our client engagement team dedicates its efforts to understand your "business need" and accordingly maps available research data to help you move forward. Call "your" client engagement executive any time of your day and get your questions answered in order to make the correct business decision.
Saving Time and Efforts
Simply share your research requirement details with us and let us do all the hard work to find required intelligence for you. When you add up our "one stop solution" and "dedicated client engagement" services mentioned above, you obviously know the time and effort saving you do by working with us.
Working with Fortune 500 organizations, we understand the importance of being flexible for payments. Share your payment terms with us and we will surely match up to them to ensure you get access to required business intelligence data without having to wait for the payment to be done.
Post-Purchase Research Support
Have questions after reading a report / datasheet bought through us? Not sure about the methodology used for data available in the research? Talk to us / Share your questions with us and if required, we will connect you with the analyst(s)/author(s) of the report(s) and ensure you get satisfactory answers for the same. Need more data / analysis / report(s) on the topic of your research/project? The RnRMarketResearch.com team is here for you 24X7 to support you with your post-purchase requirements.
Subscription Offers & Packages (Get in touch with us for more details - [email protected]
/ +1 888 391 5441 )
- Ad Hoc
- Pay - as - you - go / Bucket Subscriptions
- Fixed Cost for #of reports
- Customize / Personalize as per your needs